Deutsche upgraded the stock to "buy" from "hold" and increased the price target to $17 from $6. Deutsche said execution is improving and the new Chief Marketing Officer should increase management prowess.
The stock surged on Friday after Achillion announced its experimental hepatitis C drug ACH-3102 cured all patients in a mid-stage trial.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts